NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

US STOCKS-Wall St headed lower after five-day run on fears over virus surge

Published 07/07/2020, 13:50
Updated 07/07/2020, 13:54
© Reuters.
US500
-
UAL
-
NVAX
-
AAL
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Novavax jumps on $1.6 bln govt award for COVID-19 vaccine
* Energy companies slip on concerns over fuel demand
* Futures down: Dow 0.78%, S&P 0.65%, Nasdaq 0.31%

(Adds quote, details; updates prices)
By C Nivedita
July 7 (Reuters) - Wall Street's main indexes looked set to
open lower on Tuesday following the benchmark S&P 500's longest
streak of gains this year as investors weighed the risks to the
economy from tens of thousands of new coronavirus cases
nationwide.
Florida's greater Miami area became the latest U.S.
coronavirus hot spot to roll back its reopening while Texas
registered an all-time high in the number of people hospitalized
at any one moment with COVID-19 for the eight straight day.
Energy stocks including Occidental Petroleum Corp OXY.N
and Concho Resources CXO.N dropped about 2% on worries over
fuel demand. O/R
It looks like it will be a slight retracement of Monday and
Thursday's impressive gains, said Ryan Giannotto, director of
research at GraniteShares ETFs in New York.
U.S. stocks have climbed despite an alarming rise in
coronavirus cases as a surprise expansion in the U.S. service
sector and a record job additions in June are among the slate of
upbeat data recently that have bolstered views that an economic
recovery is underway.
The benchmark S&P 500 .SPX and Nasdaq wrapped up five
straight sessions of gains on Monday, with the latter closing at
a record level.
The conundrum of growing cases and rising stock prices
indicates that the liquidity from monetary stimulus is
overriding fears over the immediate impact of coronavirus on the
economy, Giannotto said.
At 8:10 a.m. ET, Dow e-minis 1YMcv1 were down 205 points,
or 0.78%. S&P 500 e-minis EScv1 were down 20.5 points, or
0.65% and Nasdaq 100 e-minis NQcv1 were down 33 points, or
0.31%.
Novavax Inc NVAX.O jumped 33.8% as the U.S. government
awarded $1.6 billion to the drugmaker to cover testing,
commercialization and manufacturing of a potential coronavirus
vaccine in the United States. Travel-related stocks, which were among the hardest hit
during lockdowns, fell. United Airlines Holdings Inc UAL.O and
American Airlines Group Inc AAL.O were down 2.6% and 2.3%,
respectively.
Royal Caribbean Group RCL.N and Norwegian Cruise Line
Holdings Ltd NCLH.N also dropped about 1% each, even as they
announced a joint task force to help develop safety standards
for restarting their businesses.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.